Home / NIH / Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) / Notice

Autoimmune Diseases Statistical & Clinical Coordinating Center (Ad-Sccc)

Updated

Sources Sought from the National Institutes of Health, for work in Durham, North Carolina. Due Dec 1, 2026, 3:00 PM (UTC-5), 14 days left.

Be among the first to see new Research and Development in the Physical, Engineering, and Life Sciences contracts
Only new notices that match, once a day.
Title as postedAUTOIMMUNE DISEASES STATISTICAL & CLINICAL COORDINATING CENTER (AD-SCCC)
Solicitation number75N93026R00009
AgencyNational Institutes of Health
OfficeNational Institutes of Health Niaid
Notice typeSources Sought
Set-asideNone
Trade (NAICS)Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)
Product or service codeAN12
Place of performanceDurham, North Carolina
PostedNov 16, 2026
Response deadlineDec 1, 2026, 3:00 PM (UTC-5) (14 days left)
Add the deadline toGoogle Calendar · Apple / Outlook (.ics)
Official notice
Send to a teammate

Bid documents (1)

Paid members download every document from this page, or buy this bid alone.

Federal prevailing wage rates for this place: North Carolina Davis-Bacon and SCA wage determinations.

Description

Anticipated Period of Performance The anticipated period of performance is February 1, 2027 through January 31, 2028, with an option to extend services for an additional 6 month period, through July 31, 2028. Anticipated award date: February 1, 2027 The NAICS Code is 541715. Introduction The National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), of the Department of Health and Human Services (DHHS) supports research related to the basic understanding of microbiology and immunology leading to the development of vaccines, therapeutics, and medical diagnostics for the prevention, treatment, and diagnosis of infectious and immune-mediated diseases.

The NIAID, Division of Allergy, Immunology, and Transplantation (DAIT) has a requirement to support a broad range of services critical for the design, development, execution, and analysis of clinical research in autoimmune diseases. The major clinical research programs to be supported by this solicitation include, Autoimmunity Centers of Excellence and Immune Tolerance Network (ACE), as well as investigator initiated clinical trials (IICT), and other clinical trials or study activities supported by NIAID herein collectively referred to as NIAID supported research.

Description Topic Title: Autoimmune Diseases Statistical & Clinical Coordinating Center (ADSCCC) The Division of Allergy, Immunology, and Transplantation (DAIT), National Institutes of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), project is for work related to the contract below: “Autoimmune Diseases Statistical & Clinical Coordinating Center (AD-SCCC)”, RHO Federal Systems Division, Inc. (Contract 75N93022C00003) This contract was awarded on a competitive basis for a five-year period from February 1, 2022 through January 31, 2027.

A term type/level of effort contract was awarded for the delivery of 56,170 direct labor hours per year for Years 1-5. The total value of the contract is $49,268,667 and includes options for extension of the term for a total performance period of 5 years and options for increases in the level of effort, with the purpose of establishing an Autoimmune Diseases Statistical & Clinical Coordinating Center (AD- SCCC) that will provide a broad range of support critical for the design, development, execution, and analysis of clinical research sponsored by NIAID in autoimmune diseases and diseases related to mucosal immunology and primary immune deficiencies.

The scope of clinical research to be supported by the AD- SCCC includes: (i) clinical trials at all phases to evaluate the safety and efficacy of investigational products and innovative approaches for disease treatment and prevention; (ii) studies of underlying mechanisms as integral components of clinical trials; (iii) clinical studies (e.g., genetic studies, microbiome studies, surveys of current therapies, etc.); and (iv) surrogate/biomarker studies.

The scope of statistical and clinical support functions to be performed by the AD-SCCC includes statistical design and analysis; protocol development; study initiation and management; clinical safety and pharmacovigilance support; safety oversight; management of clinical study collaboration portals; manuscript preparation and management of sample repositories. The NIAID, NIH, conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases.

The causes, pathogenesis, diagnosis, treatment, and prevention of autoimmune diseases are major areas of emphasis for NIAID’s Division of Allergy, Immunology, and Transplantation (DAIT). DAIT pursues research on autoimmune diseases by supporting investigator-initiated research projects, cooperative clinical studies, national networks of research centers, and demonstration and education research projects.

A critical component of the Division’s mission focuses on clinical research to develop new and/or improved strategies to treat or prevent autoimmune diseases through rigorous evaluations of the safety and efficacy of investigational products and therapeutic interventions, studies to elucidate underlying mechanisms of disease, studies to develop and evaluate surrogate/biomarkers of disease stage, severity and progression, and clinical studies of disease natural history.

The purpose of this acquisition is to extend the period of performance of the current contract (through July 31, 2028), beginning February 1, 2027, thereby maintaining the same direct labor hours to maintain ongoing clinical trial operations while DAIT completes the competition under the Clinical Data, Safety, and Coordinating Centers (CDSCC) NOFO. The extension retains the existing scope and contract type.

The required research and development clinical trial activities are severable in nature, the 18-month extension will be structured as two discrete option periods. Specifically, the Contractor will be responsible for the following: A. Statistical Design Provide expertise, advice and assistance pin the development of statistical design plans for the development of concept and full study proposals for NIAID supported clinical research; Provide assistance in the preparation of concept and full proposals and study-specific protocols; Provide assistance in the preparation of concept and full proposals and protocols for mechanistic studies; Provide support for preclinical safety study evaluation by providing statistical expertise for, and participate in, evaluating the accuracy and validity of data from preclinical safety studies in support of clinical trials if applicable; Provide assistance for clinical trials and mechanistic studies post-study initiation.

B. Statistical Analysis Development and preparation of the Statistical Analysis Plan (SAP) for each clinical trial in conjunction with the Study Management Teams (SMTs); Preparation of interim and final analyses; Preparation of summary data reports; Develo

The description continues in the official notice.

Contracting contact

As published on the official notice. Ask questions in writing and before any questions deadline the notice sets.

Is your business small enough?

For NAICS 541715, a business counts as small if it has no more than 11 employees (SBA size standard, with exceptions in the notes). This notice is set aside, so only businesses under that size, or in the named program, can bid. SBA table, current as of Oct 15, 2026.

Companies that win this kind of work

Federal contractors paid for research and development in the physical, engineering, and life sciences work, who also hold NIH contracts (last 12 months): possible competitors, or partners to team with.

About the buyer

The National Institutes of Health awarded $5.9 billion in contracts in the last 12 months; its biggest suppliers were Leidos Biomedical Research Inc, M. A. Mortenson Company and Deloitte Consulting LLP. See what NIH is buying now.

Research and Development in the Physical, Engineering, and Life Sciences contracts right now

There are 272 open government contract opportunities in this trade (NAICS 541715), 46 posted in the last 7 days; 31% are set aside for small businesses. The agencies buying the most are Department of the Air Force, Department of the Army and National Institutes of Health. Most of the work with a stated place is in Maryland, District of Columbia and Virginia. A notice in this trade gives a median of 47 days from posting to deadline; this one gives 15 days.

All open research and development in the physical, engineering, and life sciences contracts

Coming up in this trade

Planned contracts from the agencies' procurement forecasts, often months before a solicitation. Plans can change.

Replicable, Actionable Projects for Intelligent Transportation Systems (ITS) Deployment, Broad Agency Announcement (RAPID BAA)
Federal Highway Administration
$250M - $499M · Unrestricted · Combination
Detect Soil Drainage Using Electrical Resistivity Imaging Technique
Federal Railroad Administration
$500K - $999K · To Be Determined
Wayside Detector Technology Best Practices Phase 4
Federal Railroad Administration
$500K - $999K · To Be Determined

Recent awards in this trade

From the award notices agencies publish.

Similar open research and development in the physical, engineering, and life sciences bids

Devcom Army Research Laboratory Broad Agency Announcement for Foundational Research
Department of the Army
Due Nov 20, 2027, 11:59 PM (UTC-5)
Solicitation · Durham, NC · Posted Jun 22, 2026
2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases
National Institutes of Health
Due Dec 8, 2026, 3:00 PM (UTC-5) · 21 days left
Solicitation · Posted Nov 16, 2026
ITS4US Deployment Accelerator
Federal Highway Administration
Due Jan 11, 2027, 9:00 AM (UTC-5) · 55 days left
Solicitation · Posted Nov 16, 2026
Request for Information (RFI) — NIMHD Population Health and Clinical Research
National Institutes of Health
Due Nov 25, 2026, 4:00 PM (UTC-5) · 8 days left
Sources Sought · Posted Nov 16, 2026
Venous Thrombosis (VT)
National Aeronautics and Space Administration
Due Dec 4, 2026, 1:00 PM (UTC-6) · 17 days left
Solicitation · Houston, TX · Posted Nov 16, 2026
DIA Justification for Other Than Full and Open Competition
Defense Intelligence Agency (DIA)
Justification · Posted Nov 16, 2026